About Cepheid
Cepheid is a Healthcare company based in Sunnyvale (United States) founded in 1996, and was acquired by Danaher in September 2016. It operates as a developer of molecular diagnostic testing solutions. Cepheid has raised $19.1 million across 8 funding rounds from investors including Medtronic, NIH and Danaher. The company has 208 employees. Cepheid has completed 1 acquisition, including OncoMark. Its website cepheid.com draws about 118 thousand monthly visits. Its Indian entity Cepheid India Private Limited reported revenue of ₹720 Cr. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its competitors include Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Cepheid was founded in 1996 in Sunnyvale, United States, within the molecular diagnostics sector. Testing solutions are provided across categories including hospital-acquired infections, critical infectious diseases such as multi-drug resistant tuberculosis, influenza, respiratory syncytial virus, and enteroviral meningitis, as well as sexual health and genetic assessments like a 30-minute test for thrombosis risk. Operations focus on healthcare applications in the United States.
- Headquarters Sunnyvale, United States
- Employees 208
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website cepheid.com
- Social LinkedIn X YouTube
- Acquired by Danaher (Sep 2016)
- Legal Name Cepheid India Private Limited
- Date of Incorporation 22 Aug, 2013
- Jurisdiction Gurugram, Haryana, India
- Annual Revenue₹720 Cr
FY 2025 · +29% YoY
- Net Profit₹21.69 Cr
FY 2025 · 3% margin
- EBITDA₹55.88 Cr
FY 2025 · 8% margin
- Total Equity Funding$19.1M (USD)
in 8 rounds
- Latest Funding Round$28M (USD), Grant
Jul 2021
- InvestorsMedtronic
& 11 more
- Employee Count208
- Investments & Acquisitions
- Acquired byDanaher
(Sep 2016)
Associated legal entities of Cepheid
Cepheid operates through Cepheid India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cepheid India Private Limited CIN U33110HR2013FTC099516 | Active | 22 Aug 2013 | Gurugram, Haryana | ₹720 Cr | 208 | 3 | View details |
Apps and channels of Cepheid
its YouTube channel Cepheid has 6.57K subscribers and 30 videos.
Videos from Cepheid
The most watched videos on Cepheid's YouTube channel, Cepheid (6.57K subscribers). Click a video to play it here.
More on Cepheid.
Funding Insights of Cepheid
Cepheid has successfully raised a total of $19.1M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $28 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.1M
- Total Rounds 8
- Last Round Grant — $28M
- First Round $19.1M
(Jan 2000)
- Investors Count 11
All 8 funding rounds of Cepheid with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2021 | $28M | Grant | – | – | |
| Jan 2013 | $5.2M | Post-IPO | – | – | – |
| Jun 2012 | $19,926 | Grant | – | – | |
| Aug 2008 | $1.16M | Grant | – | – | |
| Aug 2002 | $376,000 | Grant | – | – | |
| Aug 2002 | $1.16M | Grant | – | – | |
| May 2000 | – | Grant | – | – | |
| Jan 2000 | $19.1M | Series C | – | – |
12 investors in total: 12 institutional.
Investors in Cepheid
Cepheid has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, NIH and Danaher.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech-based companies are invested in by Wheatley Partners. | – | wheatleypartners.com | Great Neck, United States | |
Biotechnology investments are targeted by the venture capital firm. | – | merlinbiomed.com | New York, United States | |
PE firm investing in the US | – | rhcapco.com | San Francisco, United States | |
VC firm making investment in early stage startups in the US | – | atvcapital.com | Menlo Park, United States | |
BARDA is focused on developing medical countermeasures for public health security. | – | medicalcountermeasures.gov | United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
- | 1958 | darpa.mil | United States | |
Investment firm offering equity and hedge funds to accredited investors worldwide. | 1960 | formulagrowth.com | New York, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for Cepheid
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cepheid India Private Limited (Cepheid)
Cepheid India Private Limited is the primary company behind Cepheid. The board of Cepheid India Private Limited currently have 3 directors; the longest-serving is Ganesh S Iyer, appointed in 2020. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ganesh S Iyer DIN 02611796 | Director | 27 Mar 2020 | 6 yrs 6 mo | Cepheid India Private Limited |
| Dhiraj Sood DIN 07945660 | Director | 28 Jul 2022 | 4 yrs 2 mo | Cepheid India Private Limited |
| Santosh Kumar Nandi Duli DIN 10780872 | Director | 24 Sep 2024 | 2 yrs | Cepheid India Private Limited |
People of Cepheid
662 people are tracked at Cepheid (213 in leadership, 449 in team); the tracked headcount is 208.
| Name | Role | Group |
|---|---|---|
Dean Henderson | Global Purchasing Director | Leadership |
Kim Gilonske | Vice President, Commercial Solutions | Leadership |
Patrick H. | Vice President, Global Strategy | Leadership |
Irene Domingo | Director, Commercial HR | Leadership |
Luben Li | Senior Vice President, Marketing & Product Management | Leadership |
Tamanna Prashar | Vice President, Global Supply Chain | Leadership |
Murali Palaniappan | Vp, Software Engineering, R&d | Leadership |
John Bishop | Chairman & CEO | Leadership |
Rachel McCrackan | Director, HR Business Partner (r&d) | Leadership |
Uma Krishnan | Director Architecture Digital Transformation | Leadership |
Kalyani Mangipudi | Director | Leadership |
Farangiz Mirzoeva | Director, Medical And Scientific Affairs | Leadership |
Gerda S. | Vice President Human Resources | Leadership |
Christine Box | Senior Director Human Resources EMEA | Leadership |
Beth McCarthy | Sr. Human Resources Business Partner | Leadership |
Yash Jani | Sr. Director, Government Programs | Leadership |
Cristina Baker M.D. | Senior Director Medical Affairs | Leadership |
Mona Zaccheus | Director Supply Planning | Leadership |
Traci Wicks | Senior Vice President, Cepheid Human Resources And Internal Communications Leader | Leadership |
Will Lee | Director Customer Defect Tracking And Resolution | Leadership |
642 more people are available in the full profile.
Complete people profiles for Cepheid
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cepheid
Figures of Cepheid India Private Limited, the primary company behind Cepheid, for FY 2025. Revenue was ₹720 Cr (+29% year on year). Net profit was ₹21.69 Cr (3% margin). EBITDA was ₹55.88 Cr (8% margin). Revenue has grown at a compounded annual rate of +17% over three years and +10% over five years.
- ₹720 CrRevenue · FY 2025 · +29% YoY
- ₹21.69 CrNet profit · 3% margin
- ₹55.88 CrEBITDA · 8% margin
- ₹1.1 LakhPaid-up capital
- 208Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cepheid India Private Limited are on its company page.
Detailed financial statements for Cepheid
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cepheid
Cepheid has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OncoMark.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Tissue-based cancer diagnostics are developed by OncoMark. | oncomark.com | Dublin, Ireland | 2011 | Dec 2021 | •••• |
Complete acquisition details for Cepheid
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cepheid
6 dated milestones of Cepheid across 25 years, from founding to its latest funding, stage changes and deals.
Competitors of Cepheid
Cepheid has 9 listed competitors in our database, 5 of them funded. They include Beckman Coulter, Blackrock Neurotech, Bruker, Complete Genomics and Esco Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beckman.com | 1935 | Brea, United States | – | – | Provider of products for biomedical testing for R&D, diagnostic and commercial applications | |
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. | |
| bruker.com | 1960 | United States | – | 9,707 | Diversified research instrument systems are manufactured and supplied. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| escolifesciences.com | 1978 | Singapore | $400M | – | Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | |
| agilent.com | 1995 | Santa Clara, United States | – | 121 | Diversified instruments are developed for scientific and laboratory management. | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| unchainedlabs.com | 2015 | Pleasanton, United States | $111M | – | Multiplex protein stability platform for biologics is developed. | |
| waters.com | 1958 | Milford, United States | – | 9,341 | Provider of laboratory management system for researchers and clinicians |
Detailed competitors of Cepheid
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cepheid
The website of Cepheid (cepheid.com) receives about 117.9K visits a month and ranks #496,659 among all websites worldwide, #489 in Biotechnology and Pharmaceuticals.
- Monthly visits117.9K
▲ 71.4% vs previous month
- Unique visitors31.5K
per month
- Global rank#496,659
among all websites
- Category rank#489
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit2.2
- Average visit55 sec
- DevicesDesktop 47% · Mobile 53%
Websites whose visitors overlap most with Cepheid. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jobs-cepheid.icims.com | jobs-cepheid.icims.com | 100% | – | – | – |
invernessmedical.com | invernessmedical.com | 83% | – | – | – |
| theravance.com | 77% | 4.4K | #4,418,406 | View details | |
| genomichealth.com | 77% | 1.9K | #5,157,031 | View details | |
| optimerpharma.com | 77% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Cepheid
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Cepheid (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cepheid
Complete news archive for Cepheid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cepheid
Cepheid was founded in 1996 and raised its 1st funding round 4 years after it was founded.
Cepheid is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Cepheid is a funded company, having raised a total of $19.1M across 8 funding rounds to date. The company's 1st funding round was a Series C of $19.1M, raised on Jan 2000.
Cepheid has 208 employees.
The primary company behind Cepheid, Cepheid India Private Limited, reported revenue of ₹720 Cr for FY 2025, up 29% year on year.
Cepheid was founded in 1996 in Sunnyvale, United States, within the molecular diagnostics sector. Testing solutions are provided across categories including hospital-acquired infections, critical infectious diseases such as multi-drug resistant tuberculosis, influenza, respiratory syncytial virus, and enteroviral meningitis, as well as sexual health and genetic assessments like a 30-minute test for thrombosis risk. Operations focus on healthcare applications in the United States.
Cepheid's top competitors include Blackrock Neurotech, Agilent and Esco Lifesciences.
Cepheid has made 1 acquisition, including OncoMark.
Cepheid operates through Cepheid India Private Limited.
Yes. Cepheid was acquired by Danaher in September 2016.
The legal entities of Cepheid currently have 3 directors, including Ganesh S Iyer, Santosh Kumar Nandi Duli, Dhiraj Sood.